Soleus Capital

PE / buyout · Greenwich, Connecticut

Founded in 2018, Soleus Capital is a private equity firm based in Greenwich, Connecticut. 15 portfolio companies and 1 fund are on record.

AUM
$2.3B
Portfolio companies
15
Recorded deals
72
12 in last 12M
Last investment
—

Soleus Capital key facts

  • Soleus Capital is a private equity firm based in Greenwich, Connecticut with 15 tracked portfolio companies.
  • Notable positions include Neurona Therapeutics, Parabilis Medicines, Abcuro.
  • Soleus Capital has 1 fund on record.
  • The team roster lists 6 people.

About Soleus Capital

Founded in 2018, Soleus Capital is a private equity firm based in Greenwich, Connecticut. The firm seeks to invest in companies operating in life sciences, including biotech, medtech, diagnostics, and genomics sectors. This firm is a Registered Investment Adviser (RIA).

Soleus Capital portfolio at a glance

15 portfolio companies are on record for Soleus Capital, including Neurona Therapeutics, Parabilis Medicines and Abcuro. The book leans Drug Discovery (6) and Biotechnology (1).

11 of the 15 carry a recorded valuation.

Soleus Capital funds

1 fund is on record for Soleus Capital. The most recent is Soleus Credit Opportunites Fund I (2025 vintage).

Soleus Capital team

6 people are on record at Soleus Capital: 3 partners and 3 others. Senior names include Benjamin Lund (Partner), David Canner (Partner) and Hatcher Snead (Director). 6 of them have a verified direct contact on file.

Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.

Free account
See more of the book
  • ·The top 10 names in the book — of 15 recorded positions
  • ·Watchlist + alerts for Soleus Capital's activity
Create free account

Membership and data by Private Market View

No card required

Portfolio

15 companies · priced for members
CompanyValuationRole
Neurona Therapeutics▮▮
Parabilis Medicines▮▮
Abcuro▮▮
+ 12 more companies · all 15, priced and dated
or a free account shows the top 10 names — no card
The whole book · Pro $99 a month

Membership and data by Private Market View

Funds

1 recorded
  • Soleus Credit Opportunites Fund I2025$144

$144 raised across the 1 fund that report a size

Team
6 people on record — 6 with verified contacts

Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.

See the team →

Frequently asked about Soleus Capital

What companies does Soleus Capital invest in?
Soleus Capital has 15 recorded portfolio companies, including Neurona Therapeutics, Parabilis Medicines, Abcuro.
What is Soleus Capital's AUM?
Soleus Capital manages approximately $2.3B in assets.